Quick Takeaways
- CGEN - COMPUGEN LTD has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: -$63,057.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 13 Insiders of COMPUGEN LTD
- Symbol
- CGEN on Nasdaq
- Location
- Holon, Israel
What Changed
- Buy value: ; sell value: $63,057.
- Net share flow: -28,875.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$63,057.
Buys
$0
Shares: 0
Insiders: 0
Sells
$63,057
Shares: 28,875
Insiders: 2
Net
-$63,057
Shares: -28,875
Insiders: -2
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 28,875 | $0 | $63,057 | -$63,057 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
COMPUGEN LTD executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Anat Cohen-Dayag | Director | $192,260 | Mixed | 18 Mar 2026 | ||
| Zurit Levine | SVP, Business Development | $71,087 | -$50,645 | -42% | Filing P/S | 07 Apr 2026 |
| Silberman David | Chief Financial Officer | $62,835 | Mixed | 18 Mar 2026 | ||
| Michelle Mahler | Chief Medical Officer | $40,931 | Mixed | 18 Mar 2026 | ||
| Sharon Kredo Russo | SVP, Research & Discovery | $34,515 | Mixed | 18 Mar 2026 | ||
| Michele Holcomb | Director | $26,550 | Mixed | 18 Mar 2026 | ||
| Eran Ophir | President and CEO, Director | $25,101 | -$12,413 | -33% | Filing P/S | 01 Apr 2026 |
| Kinneret Livnat Savitzky | Director | $23,629 | Mixed | 18 Mar 2026 | ||
| Sanford S. Zweifach | Director | $22,443 | Mixed | 18 Mar 2026 | ||
| Gilead Halevy | Director | $20,190 | Mixed | 18 Mar 2026 | ||
| Eran Perry | Director | $17,700 | Mixed | 18 Mar 2026 | ||
| Mathias Hukkelhoven | Director | $17,700 | Mixed | 18 Mar 2026 | ||
| Pierre Ferre | Chief Operating Officer | Mixed | 18 Mar 2026 |
Top shareholders of COMPUGEN LTD (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.9%
|
3,479,805
|
$5,324,102 | — | 31 Dec 2025 | |
| BRISTOL MYERS SQUIBB CO |
13D/G
|
— |
2.1%
|
1,840,136
|
$2,723,401 | $0 | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.6%
|
1,456,900
|
$2,229,057 | — | 31 Dec 2025 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
1.1%
|
1,020,000
|
$1,561,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
1,009,701
|
$1,544,843 | — | 31 Dec 2025 | |
| Taylor Frigon Capital Management LLC |
13F
|
Company |
0.97%
|
869,227
|
$1,329,917 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.74%
|
658,906
|
$1,008,126 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.44%
|
393,802
|
$602,517 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.39%
|
350,461
|
$536,205 | — | 31 Dec 2025 | |
| Yelin Lapidot Holdings Management Ltd. |
13F
|
Company |
0.36%
|
318,852
|
$487,844 | — | 31 Dec 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.34%
|
305,400
|
$467,262 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.34%
|
303,943
|
$465,033 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
3,100
|
$455,167 | — | 31 Dec 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.3%
|
272,402
|
$416,775 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.28%
|
248,884
|
$380,793 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
157,115
|
$240,386 | — | 31 Dec 2025 | |
| ROTHSCHILD INVESTMENT LLC |
13F
|
Company |
0.16%
|
143,600
|
$219,708 | — | 31 Dec 2025 | |
| Anat Cohen-Dayag |
3/4/5
|
Director |
0.12%
|
108,622
|
$192,260 | — | 18 Mar 2026 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.12%
|
106,304
|
$162,645 | — | 31 Dec 2025 | |
| Atom Investors LP |
13F
|
Company |
0.12%
|
104,396
|
$159,726 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.12%
|
103,856
|
$158,899 | — | 31 Dec 2025 | |
| MATRIX ASSET ADVISORS INC/NY |
13F
|
Company |
0.11%
|
93,833
|
$143,564 | — | 31 Dec 2025 | |
| SCHNIEDERS CAPITAL MANAGEMENT, LLC. |
13F
|
Company |
0.1%
|
90,000
|
$137,700 | — | 31 Dec 2025 | |
| Kingsview Wealth Management, LLC |
13F
|
Company |
0.09%
|
83,179
|
$127,264 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
74,300
|
$113,680 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
72,008
|
$110,172 | — | 31 Dec 2025 | |
| EAGLE ROCK INVESTMENT COMPANY, LLC |
13F
|
Company |
0.08%
|
71,212
|
$108,954 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.08%
|
67,903
|
$103,892 | — | 31 Dec 2025 | |
| EWA, LLC |
13F
|
Company |
0.07%
|
59,563
|
$91,131 | — | 31 Dec 2025 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.06%
|
55,066
|
$84,251 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
50,395
|
$77,104 | — | 31 Dec 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.06%
|
50,294
|
$76,948 | — | 31 Dec 2025 | |
| Platform Technology Partners |
13F
|
Company |
0.06%
|
50,000
|
$76,500 | — | 31 Dec 2025 | |
| Zurit Levine |
3/4/5
|
SVP, Business Development |
—
mixed-class rows
|
87,375
mixed-class rows
|
$71,087 | -$50,645 | 07 Apr 2026 | |
| Silberman David |
3/4/5
|
Chief Financial Officer |
0.04%
|
35,500
|
$62,835 | — | 18 Mar 2026 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.04%
|
40,000
|
$61,200 | — | 31 Dec 2025 | |
| Secure Asset Management, LLC |
13F
|
Company |
0.04%
|
40,000
|
$61,200 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
32,345
|
$49,486 | — | 31 Dec 2025 | |
| R Squared Ltd |
13F
|
Company |
0.03%
|
29,650
|
$45,365 | — | 31 Dec 2025 | |
| Calamos Wealth Management LLC |
13F
|
Company |
0.03%
|
29,500
|
$45,135 | — | 31 Dec 2025 | |
| Michelle Mahler |
3/4/5
|
Chief Medical Officer |
0.03%
|
23,125
|
$40,931 | — | 18 Mar 2026 | |
| SECURITY NATIONAL BANK OF SIOUX CITY IOWA /IA/ |
13F
|
Company |
0.03%
|
25,000
|
$38,250 | — | 31 Dec 2025 | |
| BANK HAPOALIM BM |
13F
|
Company |
0.03%
|
24,000
|
$37,000 | — | 31 Dec 2025 | |
| Sharon Kredo Russo |
3/4/5
|
SVP, Research & Discovery |
0.02%
|
19,500
|
$34,515 | — | 18 Mar 2026 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
17,835
|
$27,288 | — | 31 Dec 2025 | |
| Michele Holcomb |
3/4/5
|
Director |
0.02%
|
15,000
|
$26,550 | — | 18 Mar 2026 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.02%
|
17,200
|
$26,000 | — | 31 Dec 2025 | |
| Eran Ophir |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
35,750
mixed-class rows
|
$25,101 | -$12,413 | 01 Apr 2026 | |
| Kinneret Livnat Savitzky |
3/4/5
|
Director |
0.01%
|
13,350
|
$23,629 | — | 18 Mar 2026 | |
| PHILADELPHIA TRUST CO |
13F
|
Company |
0.02%
|
15,000
|
$23,000 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for COMPUGEN LTD
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Zurit Levine | CGEN | Ordinary Shares | Sale | -15.5% | $13,008 | $2.42 | -5,375 | 29,375 | 08 Apr 2026 | Direct |
| Zurit Levine | CGEN | Ordinary Shares | Options Exercise | 18.3% | 5,375 | 34,750 | 08 Apr 2026 | Direct | ||
| Zurit Levine | CGEN | Share Option (right to buy) | Options Exercise | -44.3% | -5,375 | 6,750 | 08 Apr 2026 | Direct | ||
| Zurit Levine | CGEN | Ordinary Shares | Sale | -7.84% | $5,750 | $2.30 | -2,500 | 29,375 | 07 Apr 2026 | Direct |
| Zurit Levine | CGEN | Ordinary Shares | Options Exercise | 8.51% | 2,500 | 31,875 | 07 Apr 2026 | Direct | ||
| Zurit Levine | CGEN | Share Option (right to buy) | Options Exercise | -18.4% | -2,500 | 11,125 | 07 Apr 2026 | Direct | ||
| Zurit Levine | CGEN | Ordinary Shares | Sale | -10.6% | $7,700 | $2.20 | -3,500 | 29,375 | 01 Apr 2026 | Direct |
| Zurit Levine | CGEN | Ordinary Shares | Options Exercise | 11.9% | 3,500 | 32,875 | 01 Apr 2026 | Direct | ||
| Zurit Levine | CGEN | Share Option (right to buy) | Options Exercise | -20.4% | -3,500 | 13,625 | 01 Apr 2026 | Direct | ||
| Eran Ophir | CGEN | Ordinary Shares | Sale | -33.1% | $12,413 | $2.21 | -5,625 | 11,375 | 01 Apr 2026 | Direct |
| Eran Ophir | CGEN | Ordinary Shares | Options Exercise | 49.4% | 5,625 | 17,000 | 01 Apr 2026 | Direct | ||
| Eran Ophir | CGEN | Share Option (right to buy) | Options Exercise | -18.8% | -5,625 | 24,375 | 01 Apr 2026 | Direct | ||
| Zurit Levine | CGEN | Ordinary Shares | Sale | -28.8% | $24,187 | $2.04 | -11,875 | 29,375 | 26 Mar 2026 | Direct |
| Zurit Levine | CGEN | Ordinary Shares | Options Exercise | 40.4% | 11,875 | 41,250 | 26 Mar 2026 | Direct | ||
| Zurit Levine | CGEN | Share Option (right to buy) | Options Exercise | -42.4% | -11,875 | 16,125 | 26 Mar 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.